SLC35D4

gene
On this page

Also known as MGC11386FLJ44259

Summary

SLC35D4 (solute carrier family 35 member D4, HGNC:31723) is a protein-coding gene on chromosome 18q11.2, encoding UDP-N-acetylglucosamine transporter SLC35D4 (Q24JQ0). Golgi-localized UDP-N-acetylglucosamine (UDP-GlcNAc) transporter that transports UDP-N-acetylglucosamine into Golgi lumen.

Enables UDP-N-acetylglucosamine transmembrane transporter activity. Involved in UDP-N-acetylglucosamine transmembrane transport. Located in Golgi apparatus.

Source: NCBI Gene 85019 — RefSeq curated summary.

At a glance

  • GWAS associations: 19
  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_032933

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31723
Approved symbolSLC35D4
Namesolute carrier family 35 member D4
Location18q11.2
Locus typegene with protein product
StatusApproved
AliasesMGC11386, FLJ44259
Ensembl geneENSG00000134490
Ensembl biotypeprotein_coding
OMIM615430
Entrez85019

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 14 protein_coding, 8 nonsense_mediated_decay, 4 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000383233, ENST00000460322, ENST00000473688, ENST00000475185, ENST00000477053, ENST00000482411, ENST00000497608, ENST00000542162, ENST00000577448, ENST00000577531, ENST00000578520, ENST00000578790, ENST00000580025, ENST00000581444, ENST00000582336, ENST00000583048, ENST00000584625, ENST00000907352, ENST00000907353, ENST00000907354, ENST00000907355, ENST00000938582, ENST00000938583, ENST00000938584, ENST00000938585, ENST00000951849, ENST00000951850

RefSeq mRNA: 2 — MANE Select: NM_032933 NM_001318834, NM_032933

CCDS: CCDS11876

Canonical transcript exons

ENST00000383233 — 15 exons

ExonStartEnd
ENSE000021680272343778123437961
ENSE000034603722337021623370261
ENSE000034617132336563423365668
ENSE000034673432335659423356663
ENSE000034708222337371223373763
ENSE000035480972338499023385067
ENSE000035601902337142223371470
ENSE000035609522342136723421444
ENSE000035619272339956623399647
ENSE000035694762335219623352289
ENSE000036030052330968023309744
ENSE000036233982329601323298067
ENSE000036456262343063123430677
ENSE000036832512336871523368750
ENSE000036947042337764623377671

Expression profiles

Bgee: expression breadth ubiquitous, 256 present calls, max score 99.77.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.5568 / max 54.1666, expressed in 1704 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1713505.41471691
1713460.067139
1713470.040623
1713490.027912
1713480.00643

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233699.77gold quality
pancreatic ductal cellCL:000207997.61gold quality
tendon of biceps brachiiUBERON:000818897.58gold quality
nasal cavity epitheliumUBERON:000538496.81gold quality
upper arm skinUBERON:000426396.55gold quality
kidney epitheliumUBERON:000481996.13gold quality
medial globus pallidusUBERON:000247795.65gold quality
tibialis anteriorUBERON:000138594.98silver quality
cardiac muscle of right atriumUBERON:000337994.57silver quality
ileal mucosaUBERON:000033194.24gold quality
globus pallidusUBERON:000187594.21gold quality
left ventricle myocardiumUBERON:000656693.89silver quality
upper leg skinUBERON:000426293.73gold quality
oviduct epitheliumUBERON:000480493.62gold quality
trabecular bone tissueUBERON:000248392.94gold quality
myocardiumUBERON:000234992.83gold quality
epithelium of mammary glandUBERON:000324492.50gold quality
mammary ductUBERON:000176592.46gold quality
cerebellar vermisUBERON:000472092.24gold quality
deltoidUBERON:000147691.09silver quality
epithelial cell of pancreasCL:000008391.02gold quality
vena cavaUBERON:000408790.89gold quality
quadriceps femorisUBERON:000137790.86gold quality
pigmented layer of retinaUBERON:000178290.77gold quality
cardia of stomachUBERON:000116290.63gold quality
biceps brachiiUBERON:000150790.49gold quality
vastus lateralisUBERON:000137990.40gold quality
subthalamic nucleusUBERON:000190690.35gold quality
mucosa of paranasal sinusUBERON:000503090.35gold quality
ventral tegmental areaUBERON:000269189.82gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.73
E-MTAB-7606no21.72

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

85 targeting SLC35D4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-5692A100.0074.406850
HSA-MIR-6740-5P100.0065.64932
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-511-3P99.9968.851467
HSA-MIR-569699.9872.364487
HSA-MIR-365899.9673.874379
HSA-MIR-590-3P99.9674.346478
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-335-3P99.9373.364958
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-6499-3P99.9066.381212
HSA-MIR-129-5P99.8870.263273
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-149-3P99.7268.223963
HSA-MIR-472999.6972.184233
HSA-MIR-6883-5P99.6968.053785
HSA-MIR-379-3P99.6969.601524
HSA-MIR-411-3P99.6969.631524

Literature-anchored findings (GeneRIF, showing 1)

  • The Mexican genome-wide association study signal for high serum triglycerides on chromosome 18q11.2 harbors a regulatory single-nucleotide polymorphism, rs17259126, which disrupts normal hepatocyte nuclear factor 4 alpha binding and decreases the expression of the regional TMEM241 gene. Our data suggest that decreased transcript levels of TMEM241 contribute to increased triglyceride levels in Mexicans. (PMID:27199446)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriotmem241ENSDARG00000090685
ENSDARG00000104905
mus_musculusTmem241ENSMUSG00000049411
rattus_norvegicusTmem241ENSRNOG00000023412
drosophila_melanogasterfrcFBGN0042641
caenorhabditis_elegansWBGENE00005025

Paralogs (9): SLC35C2 (ENSG00000080189), SLC35E4 (ENSG00000100036), SLC35D1 (ENSG00000116704), SLC35E1 (ENSG00000127526), SLC35D2 (ENSG00000130958), SLC35E3 (ENSG00000175782), SLC35C1 (ENSG00000181830), SLC35D3 (ENSG00000182747), SLC35E2B (ENSG00000189339)

Protein

Protein identifiers

UDP-N-acetylglucosamine transporter SLC35D4Q24JQ0 (reviewed: Q24JQ0)

Alternative names: Solute carrier family 35 member D4, Transmembrane protein 241

All UniProt accessions (8): E9PJC2, E9PLG4, Q24JQ0, F5GXY7, H0YDH1, J3QL29, J3QR22, J3QRE6

UniProt curated annotations — full annotation on UniProt →

Function. Golgi-localized UDP-N-acetylglucosamine (UDP-GlcNAc) transporter that transports UDP-N-acetylglucosamine into Golgi lumen. Contributes to lysosomal targeting of NPC2, a key protein required for lysosomal cholesterol exiting, and that utilizes the mannose-6-phosphate (M6P) modification pathway for its lysosomal targeting.

Subcellular location. Golgi apparatus. cis-Golgi network membrane.

Induction. Up-regulated by inducers of the unfolded protein response (UPR), including tunicamycin and thapsigargin.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the nucleotide-sugar transporter family. SLC35D subfamily.

Isoforms (3)

UniProt IDNamesCanonical?
Q24JQ0-11yes
Q24JQ0-22
Q24JQ0-33

RefSeq proteins (2): NP_001305763, NP_116322* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR050186TPT_transporterFamily

UniProt features (17 total): transmembrane region 10, splice variant 5, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q24JQ0-F194.110.86

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 88 (showing top): GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, chr18q11, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, LIU_COMMON_CANCER_GENES, GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY

GO Biological Process (2): UDP-N-acetylglucosamine transmembrane transport (GO:1990569), GDP-mannose transmembrane transport (GO:1990570)

GO Molecular Function (4): GDP-mannose transmembrane transporter activity (GO:0005458), UDP-N-acetylglucosamine transmembrane transporter activity (GO:0005462), antiporter activity (GO:0015297), protein binding (GO:0005515)

GO Cellular Component (2): Golgi apparatus (GO:0005794), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
pyrimidine nucleotide-sugar transmembrane transport1
purine nucleotide-sugar transmembrane transport1
purine nucleotide-sugar transmembrane transporter activity1
GDP-mannose transmembrane transport1
pyrimidine nucleotide-sugar transmembrane transporter activity1
UDP-N-acetylglucosamine transmembrane transport1
secondary active transmembrane transporter activity1
binding1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

658 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC35D4ANKRD29Q8N6D5527
SLC35D4CABLES1Q8TDN4480
SLC35D4CDH22Q9UJ99460
SLC35D4FAM53AQ6NSI3459
SLC35D4GREB1LQ9C091456
SLC35D4THOC1Q96FV9420
SLC35D4ZNF587BE7ETH6417
SLC35D4TMEM169Q96HH4403
SLC35D4ZNF521Q96K83401
SLC35D4CHST11Q9NPF2375
SLC35D4MRPL21Q7Z2W9365
SLC35D4TIGD6Q17RP2359
SLC35D4MYSM1Q5VVJ2353
SLC35D4PHTF2Q8N3S3347
SLC35D4MINDY4Q4G0A6330

IntAct

6 interactions, top by confidence:

ABTypeScore
STX7TMEM241psi-mi:“MI:0915”(physical association)0.560
TMEM241LZTFL1psi-mi:“MI:0915”(physical association)0.400
TMEM241FAAHpsi-mi:“MI:0914”(association)0.350
STX7TMEM241psi-mi:“MI:0915”(physical association)0.000

BioGRID (73): KRT40 (Two-hybrid), TMEM241 (Two-hybrid), TMEM241 (Affinity Capture-RNA), TMEM241 (Synthetic Lethality), TMEM241 (Two-hybrid), LZTFL1 (Affinity Capture-MS), AAAS (Affinity Capture-MS), ACBD5 (Affinity Capture-MS), ADPGK (Affinity Capture-MS), ALG10 (Affinity Capture-MS), AMFR (Affinity Capture-MS), ANKLE2 (Affinity Capture-MS), ANO10 (Affinity Capture-MS), ANO8 (Affinity Capture-MS), ATP13A1 (Affinity Capture-MS)

ESM2 similar proteins: A0A084AFH0, A1L3G4, A1Z7R6, A5WWC6, A7YW81, B0B8F4, B0K004, D3YVE8, O04508, O74750, O84584, P0C7Q5, P0C7Q6, P39542, P40004, P53403, Q00974, Q0Q7U7, Q0Q7U8, Q0Q7U9, Q0Q7V0, Q0V9U2, Q1PFJ4, Q23444, Q24JQ0, Q3UME2, Q5F297, Q5M7A3, Q5PT55, Q5ZJZ4, Q7RTP0, Q8BHK1, Q8MXJ9, Q8N808, Q94EI9, Q96KT7, Q9C508, Q9C654, Q9C8M1, Q9FG70

Diamond homologs: A1C9R4, A1CZJ3, A1DA52, A1L3G4, A2R9P4, A3LWX1, A4RM13, A5DIN8, A6RJQ8, A6ZQY8, A6ZTW6, A7E558, A7TES5, A7TR80, A8N9T6, A8PTV6, B0DI84, B0Y384, B3LHR7, B3LS51, B3LS52, B5VHH5, C7GSI5, C7GSI6, C7GUZ7, C8Z742, C8Z830, P0CD97, P0CE11, P0CS02, P0CS03, P0CS04, P0CS05, P40107, Q0CA27, Q0UG89, Q1DTI4, Q24JQ0, Q2AAF6, Q2HA88

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance24
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

4431 predictions. Top by Δscore:

VariantEffectΔscore
18:23213976:GAATA:Gacceptor_gain1.0000
18:23237130:T:Gacceptor_gain1.0000
18:23252948:T:TAacceptor_gain1.0000
18:23252952:T:TAacceptor_gain1.0000
18:23252958:A:AGacceptor_gain1.0000
18:23252958:A:Gacceptor_loss1.0000
18:23252959:G:GAacceptor_gain1.0000
18:23252959:GA:Gacceptor_gain1.0000
18:23252959:GAC:Gacceptor_gain1.0000
18:23252959:GACA:Gacceptor_gain1.0000
18:23252959:GACAA:Gacceptor_gain1.0000
18:23253025:G:GTdonor_gain1.0000
18:23253063:GGAG:Gdonor_gain1.0000
18:23253064:GAG:Gdonor_gain1.0000
18:23253064:GAGG:Gdonor_gain1.0000
18:23253065:AGG:Adonor_loss1.0000
18:23253067:GT:Gdonor_loss1.0000
18:23253068:T:Gdonor_loss1.0000
18:23253716:T:Aacceptor_gain1.0000
18:23253727:A:AGacceptor_gain1.0000
18:23253727:AGTCT:Aacceptor_gain1.0000
18:23253728:G:GAacceptor_gain1.0000
18:23253728:GT:Gacceptor_gain1.0000
18:23253728:GTC:Gacceptor_gain1.0000
18:23253728:GTCT:Gacceptor_gain1.0000
18:23253728:GTCTG:Gacceptor_gain1.0000
18:23253852:G:GTdonor_gain1.0000
18:23253896:G:GTdonor_gain1.0000
18:23253916:G:GTdonor_gain1.0000
18:23253932:TTGAC:Tdonor_gain1.0000

AlphaMissense

1914 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
18:23430654:A:CF32L0.993
18:23430654:A:TF32L0.993
18:23430656:A:GF32L0.993
18:23365668:A:CS189R0.990
18:23365668:A:TS189R0.990
18:23368716:T:GS189R0.990
18:23352289:A:CS224R0.989
18:23352289:A:TS224R0.989
18:23356595:T:GS224R0.989
18:23356614:G:CF217L0.989
18:23356614:G:TF217L0.989
18:23356616:A:GF217L0.989
18:23421443:A:GW41R0.989
18:23421443:A:TW41R0.989
18:23430655:A:GF32S0.989
18:23430655:A:CF32C0.974
18:23356615:A:GF217S0.973
18:23385053:A:CF98L0.973
18:23385053:A:TF98L0.973
18:23385055:A:GF98L0.973
18:23356638:G:CF209L0.970
18:23356638:G:TF209L0.970
18:23356640:A:GF209L0.970
18:23430632:C:GG40R0.969
18:23430632:C:TG40R0.969
18:23356605:G:CS220R0.966
18:23356605:G:TS220R0.966
18:23356607:T:GS220R0.966
18:23437781:C:AK24N0.965
18:23437781:C:GK24N0.965

dbSNP variants (sampled 300 via entrez): RS1000002065 (18:23342644 C>A,T), RS1000034644 (18:23387598 T>C), RS1000057030 (18:23302151 C>T), RS1000069960 (18:23289606 C>A), RS1000070076 (18:23432558 G>A), RS1000103356 (18:23395941 G>A,C), RS1000124583 (18:23292927 G>A), RS1000127176 (18:23375413 G>A), RS1000133014 (18:23434759 A>C,G), RS1000149043 (18:23317548 C>T), RS1000202976 (18:23382164 C>T), RS1000203448 (18:23344209 G>A), RS1000205672 (18:23322536 T>G), RS1000223493 (18:23336991 A>G), RS1000225182 (18:23414612 G>A)

Disease associations

OMIM: gene MIM:615430 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

19 associations (top):

StudyTraitp-value
GCST000175_6Height4.000000e-09
GCST001905_6Hypertriglyceridemia2.000000e-08
GCST003474_9Scalp hair shape6.000000e-06
GCST006946_17Worry too long after an embarrassing experience2.000000e-08
GCST008152_177Weight8.000000e-06
GCST008163_417Height2.000000e-06
GCST008163_493Height1.000000e-06
GCST008181_19Spontaneous preterm birth without premature rupture of membranes1.000000e-06
GCST010139_1Poultry consumption1.000000e-09
GCST012226_134Waist circumference adjusted for body mass index9.000000e-09
GCST012226_135Waist circumference adjusted for body mass index3.000000e-10
GCST012226_136Waist circumference adjusted for body mass index2.000000e-12
GCST012227_710Hip circumference adjusted for BMI6.000000e-11
GCST90020028_1302Hip circumference adjusted for BMI7.000000e-11
GCST90020028_1303Hip circumference adjusted for BMI2.000000e-16
GCST90020028_1304Hip circumference adjusted for BMI3.000000e-10
GCST90020029_6Waist circumference adjusted for body mass index2.000000e-08
GCST90020029_7Waist circumference adjusted for body mass index6.000000e-18
GCST90020029_8Waist circumference adjusted for body mass index6.000000e-11

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0004530triglyceride measurement
EFO:0009589worry measurement
EFO:0004338body weight
EFO:0006917spontaneous preterm birth
EFO:0008111diet measurement
EFO:0007789BMI-adjusted waist circumference
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression2
Air Pollutantsincreases abundance, increases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Particulate Matterincreases abundance, increases expression2
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
potassium chromate(VI)affects cotreatment, decreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
bisphenol Sincreases methylation1
Temozolomidedecreases expression1
Sunitinibincreases expression1
Benzo(a)pyreneaffects methylation1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Estradiolincreases expression1
Malathiondecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Tunicamycinincreases expression1
Urethanedecreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4RAHCT116-TMEM241-KO-c3Cancer cell lineMale
CVCL_D4RBHCT116-TMEM241-KO-c4Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.